Lineage Cell Therapeutics, Inc. Expected to Earn FY2024 Earnings of ($0.18) Per Share (NYSEAMERICAN:LCTX)
Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX – Free Report) – Investment analysts at Cantor Fitzgerald boosted their FY2024 earnings estimates for shares of Lineage Cell Therapeutics in a research report issued to clients and investors on Monday, August 12th. Cantor Fitzgerald analyst K. Kluska now expects that the company will post earnings of ($0.18) per share […]
More Stories
5N Plus Inc. (OTCMKTS:FPLSF) Sees Significant Decline in Short Interest
5N Plus Inc. (OTCMKTS:FPLSF – Get Free Report) saw a significant decrease in short interest in the month of October....
Lloyds Banking Group plc (NYSE:LYG) Short Interest Update
Lloyds Banking Group plc (NYSE:LYG – Get Free Report) saw a significant increase in short interest during the month of...
Short Interest in Jaguar Mining Inc. (OTCMKTS:JAGGF) Increases By 15.3%
Jaguar Mining Inc. (OTCMKTS:JAGGF – Get Free Report) was the recipient of a significant growth in short interest in the...
Short Interest in Fossil Group, Inc. 7% Senior Notes due 2026 (NASDAQ:FOSLL) Grows By 16.0%
Fossil Group, Inc. 7% Senior Notes due 2026 (NASDAQ:FOSLL – Get Free Report) was the target of a significant increase...
Humana Inc. (NYSE:HUM) Sees Large Growth in Short Interest
Humana Inc. (NYSE:HUM – Get Free Report) saw a significant increase in short interest in the month of October. As...
Stocks Sell Off at End of Week on Profit-Taking Ahead of Nvidia Earnings Report
By Panos Mourdoukoutas U.S. stocks ended the week with a sell-off due to profit-taking, rising bond yields, and disappointing earnings...